MVD and Disorder of lipid metabolism: The occurrence of lipid metabolism disorders caused by the combination of TBT with propiconazole, bifenox, or bupirimate may be partly due to the up-regulation of the Mvd gene, which is involved in cholesterol synthesis in the liver (Figure 5).